AUTOTRANSPLANTATION IN LYMPHOMA - BETTER THERAPY OR HEALTHIER PATIENTS

被引：25

作者：

SURBONE, A

ARMITAGE, JO

GALE, RP

机构：

[1] UNIV CALIF LOS ANGELES, SCH MED,DEPT MED,DIV HEMATOL ONCOL, 10833 LE CONTE AVE, LOS ANGELES, CA 90024 USA

[2] MEM SLOAN KETTERING CANC CTR, NEW YORK, NY 10021 USA

[3] UNIV NEBRASKA, MED CTR, OMAHA, NE 68198 USA

来源：

ANNALS OF INTERNAL MEDICINE | 1991年 / 114卷 / 12期

关键词：

BONE MARROW TRANSPLANTATION; TRANSPLANTATION; AUTOLOGOUS; AUTOTRANSPLANTATION; LYMPHOMA; LARGE-CELL; CHEMOTHERAPY;

D O I：

10.7326/0003-4819-114-12-1059

中图分类号：

R5 [内科学];

学科分类号：

1002 ; 100201 ;

摘要：

Bone marrow autotransplantation has been shown to be potentially curative in patients with relapsed lymphoma. A review of the literature shows a higher cure rate for autotransplantation in comparison with salvage chemotherapy as rescue treatment for patients with relapsed or recurrent lymphoma. However, the patients treated in two groups are not entirely comparable (for example, older patients were included in the salvage chemotherapy series). The question of superiority remains to be answered definitely.

引用

页码：1059 / 1060

页数：2

共 13 条

[1]

ARMITAGE JO, 1989, BLOOD, V73, P1749

[2] PROGNOSTIC FACTORS IN AGGRESSIVE MALIGNANT-LYMPHOMAS - DESCRIPTION AND VALIDATION OF A PROGNOSTIC INDEX THAT COULD IDENTIFY PATIENTS REQUIRING A MORE INTENSIVE THERAPY [J].